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Background: Neisseria gonorrohoeae is an exclusive human pathogen that primarily infects the urogenital
epithelia. Infections caused by N. gonorrhoeae are considered the second major cause of sexually transmitted
disease after Chlamydiae worldwide. Although the urethra and the uterine cervix serve as the initial sites for
gonococcal infections in men and women, infection of the conjunctiva, pharynx, tendons, joints, as well as rectal
mucosa are also reported.
Objectives: The objectives of this study were to introduce molecular techniques such as polymerase chain
reaction (PCR) to detect N. gonorrhoeae directly from endocervical swabs. In addition, it provides a picture of
Neisseria gonorrohea infection among a sample of Palestinian women in West Bank.
Methods: Two hundred and thirteen endocervical swabs were collected from sexually active married women with
endocervical abnormalities attending healthcare clinics. DNA was extracted directly from the swabs and PCR
was performed using specific primers targeting the orf1 region of the genome.
Results: The results obtained indicated that the percentage of positive cases of N. gonorrhoeae among the
women tested was 1.40%.
Conclusion: Implementing guidelines for comprehensive screening of men and women with more sensitive tests
may improve detection and management of sexually transmitted infections.
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Brief Communication (Original)
Gonorrhea is one of the most prevalent
sexually transmitted diseases (STD) worldwide [1].
The etiological agent of gonorrhea is Neisseria
gonorrhoeae. According to World Health
Organization (WHO) estimates, the global incidence
of gonorrhoeae is approximately 60 million cases per
year [2]. According to CDC estimates, the incidence
of gonorrhoeae in the USA is about 700,000 cases
per year [3].
Urogenital disease due to gonorrheal infection
most often occurs as asymptomatic (50%) or mild
urethritis and cervicitis. It can also produce serious
sequelae, including endometritis and salpingitis in
women, resulting in spontaneous abortion, premature
delivery, and ectopic pregnancy [4, 5]. The presence
of symptoms is dependent on the site of infection. In
females, the infection is accompanied by purulent
(or pus-like) discharge, which may be foul or bad
smelling, inflammation, redness, swelling, dysuria, and
a burning sensation during urination. Infections with
N. gonorrhoeae could facilitate HIV infection
especially in the young adults. The treatment of STDs
reduces the transmission of HIV by more than 40-
60% [6-8].
Transmission of N. gonorrhoeae to neonates
usually occurs during delivery as they pass through
the infected birth canal. Unsafe sexual behavior
increases the risk of contacting gonorrhea while the
use of condoms reduces transmission [9]. There is no
known immunity to gonorrhea and no vaccine. All
sexually active persons in a population are susceptible
to the infection.
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Gonorrhea is the second most common STD
worldwide. In the Middle East, few studies have been
carried out to determine the incidence or prevalence
rate of gonorrhea. In Saudi Arabia, the incidence of
STDs from 1995 to 1999 ranged from 936 to about
1747 cases per 100,000 populations [10].
In Palestine, the prevalence of STDs has not been
determined. This study was conducted in cooperation
with the Governmental Primary Health Care Division
in the West Bank, Palestine. Genital infection caused
by N. gonorrhoeae in females is known to contribute
to dissemination of gonorrhea in the community.
The objective of this study was to provide information
regarding the prevalence of N. gonorrhoeae infection
among Palestinian women suffering from endocervical
abnormalities. We introduced specific and sensitive
molecular methods not used before, such as
polymerase chain reaction (PCR), so that such
methods might be used by the Ministry of Health of
Palestine for comprehensive screening of men and
women for gonorrhea as well as other STDs.
Materials and methods
Study samples
Two hundred thirteen endocervical swabs were
randomly collected from sexually active women, 16-
25 years old, attending primary health care clinics in
Ramallah area in the West Bank of Palestine, and
suffering from endocervical abnormalities. Specimens
were collected by the attending physicians. Single and
pregnant women were excluded.
Specimen collection and processing
Two sterile wooden cotton swabs were used to
collect the endocervical specimens from each woman.
The first cotton swab was used to remove excess
mucus from the endocervical area while the second
swab was inserted into the endocervical canal, rotated
360 degree in one direction carefully withdrawn to
avoid contamination, placed in the transport media
(Sterile Amies Clear, Biomed) and stored at -20oC to
be  used for DNA extraction.
DNA extraction
DNA was extracted as described by Santos
et al. 2003 [11]. Briefly, endocervical swabs were put
in eppendorf tubes and centrifuged at 8000 rpms for
two minutes. Triton (4 μL) and proteinase K (4 μL,
from 10 mg/mL stock) were added to each tube and
the mixture incubated at 55oC for 90 minutes.
Proteinase K was inactivated by placing the tubes
at 95oC for 30 minutes. Then, the samples were
centrifuged and the supernatant containing DNA was
stored at -20oC for subsequent PCR amplification.
Polymerase chain reaction
For PCR, a set of primers were used to target
the orf1 gene to amplify a 260 bp product specific for
N. gonorrhoeae. The sequence for the forward
primer Ngu1, 5'-CAA CTA TTC CCG ATT GCG A-
3' targeting the region from nucleotide 221 to 239, and
the reverse primer Ngu2, 5'-GTT ATA CAG CTT CGC
CTG AA-3' targeting nucleotide 461 to 480 was used
The PCR reaction was performed in 100 mL reaction
volumes containing 50 pmol of each oligonucleotide
primer, ready mix (in-vitrogen) and 50 ng of genomic
DNA. For each PCR amplification, a positive control,
a negative control and DNA ladder (Promega) was
used.
Thermal cycling for N. gonorrhoeae included an
initial denaturation step at 94oC for five minutes
followed by 40 cycles. Each cycle consisted of 94oC
for 30 seconds, 52oC for 30 seconds and 72oC for one
minute with the final extension step at 72oC for 10
minutes [12]. The PCR product was run on 2%
agarose gel in 1x TAE buffer containing 0.5 μg/mL
ethidium bromide. Samples were electrophoresed
at 5-8 V/cm. The size of the DNA amplicons was
determined by comparing them with a 1kbp DNA ladder
included in each gel. Samples were visualized under
UV and photographed using a Polaroid camera.
Analysis of PCR products
Seven and a half microliter (7.5 μL) of each PCR
reaction was mixed with 2 μL of DNA gel loading dye
and run on a 2% agarose gel in 1x TAE buffer
containing 0.5 μg/mL ethidium bromide. Samples were
electrophoresed at 5-8 V/cm. The size of the DNA
amplicons was determined by comparing them with a
1kbp DNA ladder included with each gel. Samples
were visualized under UV and photographed using a
Polaroid camera (Fotodyne, UK).
Ethical consideration
This study was conducted in cooperation with
the Governmental Primary Health Care Division in
the West Bank, Palestine. Informed consent according
to WHO recommendations for STDs was obtained
from all women participating in this study and the
privacy of the human subjects was protected.
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Results
Endocervical swabs from 213 women attending
primary health care clinics in the West bank, Palestine
were collected. DNA was extracted from the
endocervical swabs and PCR was performed
using primers targeting the orf1 gene specific for N.
gonorrhoeae.
The percentage of positive cases of N.
gonorrhoeae infections was found to be 1.40%. A
representative photograph of the results obtained by
PCR is shown in Fig. 1
Discussion
Gonorrhea is a major sexually transmitted
infection and the second most common STD
worldwide. The rising number of cases, the emergence
of antibiotic resistance [3], and the increasing risk of
sexual transmission of HIV [3, 4], emphasizes the
concern by major health organizations regarding N.
gonorrhoeae.
In the Middle East, data for the incidence and
prevalence of gonorrhea are either estimated or
unavailable. In Palestine, there is no available literature
regarding the incidence of gonorrhea. Only few studies
have been carried out on other sexually transmitted
pathogens such as Trichomonas vaginalis [13]. This
can be due to the reliance of laboratories in these
countries on conventional methods such as culture
and Gram stain to detect N. gonorrhoeae. False-
negative results can be attributed to the fastidious
nature of this organism, delays in  specimen transport
and processing, storage, and inhibition of growth by
certain components of the selective media used [14].
To obtain reliable and accurate data regarding
prevalence and incidence of gonorrhoeae, it is
important to utilize nucleic based methods such as
PCR, which has high sensitivity and specificity. In
addition, it provides an alternative method for
screening both symptomatic and asymptomatic
individuals for N. gonorrhoeae [12, 14].
In this study, the first conducted in this country,
we used PCR to detect N. gonorrhoeae directly from
endocervical swabs. The prevalence among our
study samples was found to be 1.4%. This result is an
agreement with studies conducted in Israel [15].
Although the results obtained are in agreement with
other Middle Eastern countries such as Saudi Arabia
and Israel, it is much higher than rates obtained in
industrialized countries in Europe and North America.
In conclusion, control of gonorrhea is not a simple
task. Due to the fastidious nature of this organism, it
is extremely important to implement highly sensitive
and specific molecular methods for the detection of
this organism. This can contribute to enhanced
diagnosis, proper treatment, and surveillance of
antimicrobial resistance.
The authors have no conflict of interest to report.
Fig. 1 Representative agarose gel showing the PCR products for the orf1 gene. Lane 1: positive control for Neisseria
gonorrhoeae, Lane 2: positive sample, Lane 3: positive sample, Lane 4: 100 bp ladder, Lane 5 and 6: negative
samples, Lane 7: negative control, Lane 8: blank.
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